Literature DB >> 28942873

Biomarkers and new-onset atrial fibrillation to assess atrial cardiomyopathy.

Dominik Linz1, Adrian D Elliott1, Thomas H Marwick2, Prashanthan Sanders3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28942873     DOI： 10.1016/j.ijcard.2017.08.031

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN： 0167-5273            Impact factor:   4.164


× No keyword cloud information.
  4 in total

Review 1.  Left Atrial Cardiomyopathy - A Challenging Diagnosis.

Authors:  Fabienne Kreimer; Michael Gotzmann
Journal:  Front Cardiovasc Med       Date:  2022-06-30

Review 2.  Putative protective effects of sodium-glucose cotransporter 2 inhibitors on atrial fibrillation through risk factor modulation and off-target actions: potential mechanisms and future directions.

Authors:  Syona S Shetty; Andrew Krumerman
Journal:  Cardiovasc Diabetol       Date:  2022-06-28       Impact factor: 8.949

3.  The Biomarkers NT-proBNP and CA-125 are Elevated in Patients with Idiopathic Atrial Fibrillation.

Authors:  Elton Amp Dudink; Bob Weijs; Samantha Tull; Justin Glm Luermans; Larissa Fabritz; Winnie Chua; Michiel Rienstra; Isabelle C Van Gelder; Ulrich Schotten; Paulus Kirchhof; Harry Jgm Crijns
Journal:  J Atr Fibrillation       Date:  2018-12-31

4.  Concealed Coronary Atherosclerosis In Idiopathic Paroxysmal Atrial Fibrillation is Associated with Imminent Cardiovascular Diseases.

Authors:  Eamp Dudink; B Weijs; Jglm Luermans; Fecm Peeters; S Altintas; K Vernooy; Lafg Pison; R J Haest; J A Kragten; Bljh Kietselaer; J E Wildberger; Hjgm Crijns
Journal:  J Atr Fibrillation       Date:  2020-12-31
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.